Globus Medical (GMED) Short Interest Ratio & Short Volume $62.54 +2.04 (+3.38%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$62.54 -0.01 (-0.01%) As of 08/22/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Globus Medical Short Interest DataGlobus Medical (GMED) has a short interest of 4.78 million shares, representing 4.33% of the float (the number of shares available for trading by the public). This marks a 5.75% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 1.49 million shares to cover all short positions.Current Short Interest4,780,000 sharesPrevious Short Interest4,520,000 sharesChange Vs. Previous Month+5.75%Dollar Volume Sold Short$251.49 millionShort Interest Ratio2.8 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares135,060,000 sharesShort Percent of Float4.33%Today's Trading Volume719,357 sharesAverage Trading Volume1,492,223 sharesToday's Volume Vs. Average48% Short Selling Globus Medical? Sign up to receive the latest short interest report for Globus Medical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGMED Short Interest Over TimeGMED Days to Cover Over TimeGMED Percentage of Float Shorted Over Time Globus Medical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20254,780,000 shares $251.49 million +5.8%4.3%2.8 $52.61 7/15/20254,520,000 shares $252.49 million +4.9%N/A2.8 $55.86 6/30/20254,310,000 shares $254.20 million -7.1%3.9%2.9 $58.98 6/15/20254,640,000 shares $273.06 million -10.1%4.2%3.2 $58.85 5/31/20255,160,000 shares $305.37 million +14.4%4.7%3.4 $59.18 5/15/20254,510,000 shares $260.50 million +6.9%4.1%2.9 $57.76 4/30/20254,220,000 shares $303.04 million -0.5%N/A2.9 $71.81 4/15/20254,240,000 shares $306.49 million +28.5%3.8%3.4 $72.29 3/31/20253,300,000 shares $241.49 million +36.4%3.0%2.4 $73.18 3/15/20252,420,000 shares $172.32 million -7.6%2.2%1.9 $71.21 Get the Latest News and Ratings for GMED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Globus Medical and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,620,000 shares $210.49 million +12.9%2.4%2.3 $80.34 2/15/20252,320,000 shares $194.86 million +6.4%2.1%2.1 $83.99 1/31/20252,180,000 shares $202.09 million -12.8%N/A1.9 $92.70 1/15/20252,500,000 shares $226.40 million +0.4%N/A2.4 $90.56 12/31/20242,490,000 shares $205.95 million +4.6%N/A2.6 $82.71 12/15/20242,380,000 shares $196.16 million -2.5%N/A2.7 $82.42 11/30/20242,440,000 shares $208.89 million -12.5%N/A3 $85.61 11/15/20242,790,000 shares $226.27 million -2.5%N/A3.5 $81.10 10/31/20242,860,000 shares $210.32 million +0.7%N/A3.5 $73.54 10/15/20242,840,000 shares $210.30 million -16.7%N/A3.5 $74.05 9/30/20243,410,000 shares $243.95 million -3.4%N/A4.3 $71.54 9/15/20243,530,000 shares $246.22 million -19.6%N/A4.1 $69.75 8/31/20244,390,000 shares $319.15 million No ChangeN/A4.8 $72.70 8/15/20244,390,000 shares $301.99 million -9.1%N/A4.6 $68.79 7/31/20244,830,000 shares $347.86 million -29.0%N/A4.6 $72.02 7/15/20246,800,000 shares $489.87 million -5.0%N/A6.7 $72.04 6/30/20247,160,000 shares $490.39 million +4.4%N/A7 $68.49 6/15/20246,860,000 shares $450.08 million -2.6%N/A6.6 $65.61 5/31/20247,040,000 shares $472.45 million -2.0%N/A6.5 $67.11 5/15/20247,180,000 shares $463.61 million -20.1%N/A6.5 $64.57 4/30/20248,990,000 shares $447.61 million +19.7%N/A8 $49.79 4/15/20247,510,000 shares $389.09 million -3.2%N/A7.2 $51.81 3/31/20247,760,000 shares $416.25 million +32.4%N/A6.7 $53.64 3/15/20245,860,000 shares $301.26 million +2.3%N/A5.1 $51.41 2/29/20245,730,000 shares $309.36 million -0.9%N/A4.8 $53.99 2/15/20245,780,000 shares $309.40 million +8.7%N/A4.7 $53.53 1/31/20245,320,000 shares $280.66 million +55.1%N/A4.3 $52.76 1/15/20243,430,000 shares $192.83 million No ChangeN/A2.6 $56.22 12/31/20233,430,000 shares $182.78 million +0.9%N/A2.7 $53.29 12/15/20233,400,000 shares $168.44 million +6.3%N/A2.6 $49.54Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/30/20233,200,000 shares $143.74 million -13.0%N/A2.3 $44.92 11/15/20233,680,000 shares $168.58 million -7.8%N/A1.8 $45.81 10/31/20233,990,000 shares $182.38 million -6.3%N/A2 $45.71 10/15/20234,260,000 shares $226.29 million -4.1%N/A2.3 $53.12 9/30/20234,440,000 shares $220.45 million +3.0%N/A2.5 $49.65 9/15/20234,310,000 shares $215.59 million -59.2%N/A2.6 $50.02 8/31/202310,570,000 shares $572.31 million +32.6%N/A6.8 $54.15 8/15/20237,970,000 shares $455.09 million -1.5%10.3%9.3 $57.10 7/31/20238,090,000 shares $487.42 million -1.6%10.5%8.7 $60.25 7/15/20238,220,000 shares $509.23 million +3.9%10.6%7.6 $61.95 6/30/20237,910,000 shares $470.96 million +2.3%10.2%7 $59.54 6/15/20237,730,000 shares $453.98 million -3.9%10.0%6.2 $58.73 5/31/20238,040,000 shares $435.21 million +4.4%10.4%5.9 $54.13 5/15/20237,700,000 shares $436.28 million +24.0%10.0%5.3 $56.66 4/30/20236,210,000 shares $361.05 million +7.4%8.0%3.5 $58.14 4/15/20235,780,000 shares $332.58 million +13.1%7.5%3.7 $57.54 3/31/20235,110,000 shares $289.43 million +12.8%6.6%3.4 $56.64 3/15/20234,530,000 shares $237.87 million +17.1%5.9%3.4 $52.51 2/28/20233,870,000 shares $225.78 million +50.0%5.0%3.4 $58.34 2/15/20232,580,000 shares $158.57 million -47.4%3.3%2.5 $61.46 1/31/20234,900,000 shares $369.95 million +1.0%6.4%6.4 $75.50 1/15/20234,850,000 shares $360.84 million +2.1%6.3%8.5 $74.40 12/30/20224,750,000 shares $352.78 million -5.6%6.2%8.1 $74.27 12/15/20225,030,000 shares $363.92 million -15.2%6.6%8.6 $72.35 11/30/20225,930,000 shares $438.17 million +2.4%7.7%9.5 $73.89 11/15/20225,790,000 shares $415.61 million +7.6%7.5%9.4 $71.78 10/31/20225,380,000 shares $360.46 million +9.4%N/A9.4 $67.00 10/15/20224,920,000 shares $298.99 million +0.6%N/A8.4 $60.77 9/30/20224,890,000 shares $291.30 million +1.0%N/A8.3 $59.57 9/15/20224,840,000 shares $297.71 million -7.5%N/A8 $61.51 8/31/20225,230,000 shares $309.56 million +0.8%N/A8.3 $59.19 8/15/20225,190,000 shares $350.53 million +3.0%N/A8.3 $67.54 7/31/20225,040,000 shares $295.80 million +1.4%6.7%7.1 $58.69 7/15/20224,970,000 shares $280.01 million +5.1%6.6%6.1 $56.34 6/30/20224,730,000 shares $265.54 million +2.2%6.3%5.4 $56.14 6/15/20224,630,000 shares $257.34 million +2.7%6.2%5.3 $55.58 5/31/20224,510,000 shares $300.37 million +2.5%N/A5.4 $66.60 5/15/20224,400,000 shares $279.80 million +30.6%N/A5.2 $63.59 4/30/20223,370,000 shares $223.16 million -13.8%N/A4.3 $66.22 4/15/20223,910,000 shares $303.03 million +51.0%N/A5.5 $77.50 3/31/20222,590,000 shares $191.09 million +14.6%N/A4.4 $73.78 3/15/20222,260,000 shares $148.91 million +137.5%N/A4.2 $65.89 2/28/2022951,500 shares $66.91 million -25.7%N/A1.7 $70.32 2/15/20221,280,000 shares $88.64 million +34.1%N/A2.4 $69.25 1/31/2022954,600 shares $63.70 million +27.8%N/A1.8 $66.73 1/15/2022747,000 shares $54.87 million -19.8%N/A1.5 $73.45 12/31/2021931,300 shares $67.24 million -9.6%N/A1.9 $72.20 12/15/20211,030,000 shares $68.95 million +27.4%N/A2.1 $66.94 11/30/2021808,400 shares $50.62 million +3.4%N/A1.8 $62.62 11/15/2021782,200 shares $55.37 million -31.4%N/A1.7 $70.79Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 10/29/20211,140,000 shares $87.97 million -14.9%N/A2.7 $77.17 10/15/20211,340,000 shares $102.42 million +14.5%1.7%3.2 $76.43 9/30/20211,170,000 shares $89.65 million +1.7%1.5%2.7 $76.62 9/15/20211,150,000 shares $93.29 million +0.9%1.5%2.5 $81.12 8/31/20211,140,000 shares $93.02 million -1.7%1.5%2.7 $81.60 8/13/20211,160,000 shares $88.64 million -17.1%1.5%2.9 $76.41 7/30/20211,400,000 shares $116.44 million -3.5%1.8%3.3 $83.17 7/15/20211,450,000 shares $114.62 million +0.7%1.9%3.3 $79.05 6/30/20211,440,000 shares $111.64 million +5.1%1.9%3.3 $77.53 6/15/20211,370,000 shares $99.94 million +13.2%1.8%3.3 $72.95 5/28/20211,210,000 shares $87.19 million -2.4%1.6%2.7 $72.06 5/14/20211,240,000 shares $88.45 million -37.1%N/A2.6 $71.33 4/30/20211,970,000 shares $142.84 million +28.8%N/A4 $72.51 4/15/20211,530,000 shares $105.46 million +19.5%2.0%3.3 $68.93 3/31/20211,280,000 shares $78.18 million +6.7%1.7%2.8 $61.08 3/15/20211,200,000 shares $74.93 million -4.8%N/A2.4 $62.44 2/26/20211,260,000 shares $78.09 million -15.4%N/A2.4 $61.98 2/12/20211,490,000 shares $99.73 million +7.2%N/A2.7 $66.93 1/29/20211,390,000 shares $87.58 million +6.1%1.8%2.6 $63.01 1/15/20211,310,000 shares $85.22 million -9.0%1.7%2.3 $65.05 12/31/20201,440,000 shares $93.48 million +2.9%1.9%2.4 $64.92 12/15/20201,400,000 shares $86.79 million -27.8%1.9%2.3 $61.99 11/30/20201,940,000 shares $116.24 million -2.5%2.6%3.3 $59.92 11/15/20201,990,000 shares $112.79 million -8.7%2.6%3.4 $56.68 10/30/20202,180,000 shares $114.38 million +6.3%2.9%3.7 $52.47 10/15/20202,050,000 shares $112.32 million +16.5%2.8%3.4 $54.79 9/30/20201,760,000 shares $87.16 million +29.4%2.4%2.8 $49.52 9/15/20201,360,000 shares $74.08 million -30.3%1.8%1.6 $54.47 8/31/20201,950,000 shares $110.21 million -15.2%2.6%2 $56.52 GMED Short Interest - Frequently Asked Questions What is Globus Medical's current short interest? Short interest is the volume of Globus Medical shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 4,780,000 shares of GMED short. 4.33% of Globus Medical's shares are currently sold short. Learn More on Globus Medical's current short interest. What is a good short interest ratio for Globus Medical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMED shares currently have a short interest ratio of 3.0. Learn More on Globus Medical's short interest ratio. Which institutional investors are shorting Globus Medical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Globus Medical: Group One Trading LLC, Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Globus Medical? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.33% of Globus Medical's floating shares are currently sold short. Is Globus Medical's short interest increasing or decreasing? Globus Medical saw a increase in short interest in July. As of July 31st, there was short interest totaling 4,780,000 shares, an increase of 5.8% from the previous total of 4,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Globus Medical's short interest compare to its competitors? 4.33% of Globus Medical's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Globus Medical: DexCom, Inc. (2.17%), STERIS plc (1.01%), Insulet Corporation (2.50%), Hologic, Inc. (2.00%), Baxter International Inc. (3.73%), Masimo Corporation (6.54%), Teleflex Incorporated (2.00%), Integer Holdings Corporation (6.80%), Alphatec Holdings, Inc. (10.83%), AtriCure, Inc. (4.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Globus Medical stock? Short selling GMED is an investing strategy that aims to generate trading profit from Globus Medical as its price is falling. GMED shares are trading up $2.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Globus Medical? A short squeeze for Globus Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GMED, which in turn drives the price of the stock up even further. How often is Globus Medical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMED, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies DXCM Short Squeeze STE Short Squeeze PODD Short Squeeze HOLX Short Squeeze BAX Short Squeeze MASI Short Squeeze TFX Short Squeeze ITGR Short Squeeze ATEC Short Squeeze ATRC Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:GMED) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Globus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Globus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access